Hackensack Meridian Health/Raritan Bay Medical Center
Internal Medicine residency · Perth Amboy, NJ · Hackensack Meridian Health programs · Program website
Fellowships here: Gastroenterology
Some matches pending. 3 people are awaiting a decision between possible publication profiles, so these numbers may change.
Residents here publish more than most (9th of 54 internal medicine residencies with complete rosters, by share who have published). 11% of their papers have a co-author at Hackensack Meridian Health, most often Kousik Surya Sridharan, Ayesha Arshad Ali, and Adeel A. Butt. How residents publish ↓
- 28
- Residents
- 36%
- Have published here
- 1.29
- Papers per resident-year
- 28%
- Papers led by a resident
- 11%
- With a co-author at Hackensack Meridian Health
Roster from the program's own pages 1 · 2 · 3 · 4, collected 2026-11-08: 28 current residents in 3 classes. Something off? Tell us
Papers
By this program's leadership and residents since 2022, 71 in all · 47 with a resident author. Updated 2026-11-09.
- POSTER: MDS-1311: Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort StudyShankar Biswas et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- POSTER: MPN-1283: Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort StudyKumar Anmol et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- POSTER: MDS-1271: Comparative Outcomes With Luspatercept Versus Erythropoiesis-Stimulating Agents in Lower-Risk Myelodysplastic Syndromes: A Propensity Score-Matched Retrospective Cohort StudyShankar Biswas et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- POSTER: MDS-1298: Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score–Matched TriNetX AnalysisKofi Boakye Opoku et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- POSTER: AML-1755: Preventable Leukemia in the Workplace: Global Burden of Occupational Benzene-Attributable Leukemia, 1990–2023Hardik Jain et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
- Real-time genomic characterization of pediatric acute leukemia using adaptive samplingJeremy Wang et al. · UNC Libraries · 2026
- Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019Adeel A. Butt et al. · IJID Regions · 2026 · PubMed
- Decoding Small Cell Lung Cancer: Molecular Subtypes, Surface Antigens, and the Target-Modality ProblemMijail I. Zambrano Iglesias et al. · Cancers · 2026 · PubMed
- Real-World Survival and Toxicity Outcomes of Fluorouracil With vs. Without Leucovorin in Metastatic Colorectal CancerBugra Zengin et al. · Journal of Gastrointestinal Cancer · 2026 · PubMed
- Lung Cancer Disparities in the United States: The Role of Smoking, Comorbidities, Socioeconomic Status, and Regional VariationBugra Zengin et al. · Cureus · 2026 · PubMed
Trainees aren't named, for privacy. A paper is included when one of its authors is a current resident or fellow, or a graduate of the last two years, and it came out during their training.
How residents publishauthor positions, co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 11 of 28 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Mayer R. Ezer, M.D., FACPPD (unresolved) | — | — | 0 | 0 | 0 | — |
| Michael Carson, M.D. | Potassium and Related Disorders; Airway Management and Intubation Techniques | 12 | 4 | 0 | 2 | 1.25 |
| Mohammed Islam, M.D. (unresolved) | — | — | 0 | 0 | 0 | — |
| Sonya Shah, M.D. (unresolved) | — | — | 0 | 0 | 0 | — |
28 trainees are counted above but never listed by name.
Internal Medicine at Hackensack Meridian Healthshared by every program there, not this program's own
Institution-level: all internal medicine publications from Hackensack Meridian Health + Raritan Bay Medical Center and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Internal Medicine research topics at Hackensack Meridian Health
Papers in the window; each links to the list on OpenAlex.
- Tuberculosis Research and Epidemiology 66
- Antifungal resistance and susceptibility 45
- Lung Cancer Diagnosis and Treatment 42
- CAR-T cell therapy research 32
- Multiple Myeloma Research and Treatments 29
- SARS-CoV-2 and COVID-19 Research 20
- Cancer Immunotherapy and Biomarkers 19
- Mechanical Circulatory Support Devices 19
Most cited at Hackensack Meridian Health since 2024
All internal medicine papers there on OpenAlex
- Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsisOliver Liesenfeld et al. · Nature Medicine · 2025 · PubMed · cited 45
- Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphomaXavier Deschênes‐Simard et al. · Blood Advances · 2025 · PubMed · cited 29
- Clinical management of the Impella 5.5 pumpAlexander M. J. Bernhardt et al. · The Journal of Heart and Lung Transplantation · 2025 · PubMed · cited 46
- Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer et al. · Nature · 2024 · PubMed · cited 49
- Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumMichael David Jain et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 92
- Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural InvasionNasser Khaled Altorki et al. · JAMA Oncology · 2024 · PubMed · cited 37
- Clostridial Myonecrosis: A Comprehensive Review of Toxin Pathophysiology and Management StrategiesHussain Hussain et al. · Microorganisms · 2024 · PubMed · cited 28
- Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung diseaseVeronique Anne Dartois et al. · Nature Reviews Drug Discovery · 2024 · PubMed · cited 122
- Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W. Shurtleff et al. · Journal of Medicinal Chemistry · 2024 · PubMed · cited 30
- Fungicide-tolerant persister formation during cryptococcal pulmonary infectionWeixin Ke et al. · Cell Host & Microbe · 2024 · PubMed · cited 45
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/hackensack-meridian-health-raritan-bay-medical-c-im"><img src="https://openprograms.org/programs/hackensack-meridian-health-raritan-bay-medical-c-im/badge.svg" alt="Hackensack Meridian Health/Raritan Bay Medical Center Internal Medicine residency on OpenPrograms" height="20"></a><iframe src="https://openprograms.org/embed/hackensack-meridian-health-raritan-bay-medical-c-im" title="Recent papers, Hackensack Meridian Health/Raritan Bay Medical Center Internal Medicine residency" width="100%" height="520" style="border:0" loading="lazy"></iframe>Something wrong or missing on this page? Use the correction form below; changes show up in both.